Dalal RS, McClure EL, Marcus J, Allegretti JR, et al. Comparative Long-Term Drug Survival of Vedolizumab, Adalimumab, and Infliximab in Biologic-Naive Patients with Ulcerative Colitis. Dig Dis Sci 2022 Apr 12. pii: 10.1007/s10620-022-07472.
PMID: 35415826